- Report
- April 2024
- 402 Pages
Global
From €4377EUR$4,950USD£3,778GBP
- Report
- January 2024
- 213 Pages
Global
From €4111EUR$4,650USD£3,549GBP
- Report
- September 2022
- 110 Pages
Global
From €4863EUR$5,500USD£4,198GBP
- Report
- July 2024
- 150 Pages
Global
From €5261EUR$5,950USD£4,542GBP
- Report
- May 2024
- 125 Pages
Global
From €5261EUR$5,950USD£4,542GBP
- Report
- May 2023
- 163 Pages
Global
From €5261EUR$5,950USD£4,542GBP
- Report
- January 2023
- 170 Pages
China
From €2202EUR$2,490USD£1,901GBP
- Report
- January 2023
- 343 Pages
Global
From €4421EUR$5,000USD£3,817GBP
- Report
- August 2024
- 143 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2023
- 145 Pages
Global
From €2785EUR$3,150USD£2,404GBP
- Report
- February 2025
- 85 Pages
India
From €3095EUR$3,500USD£2,672GBP
- Report
- July 2024
- 185 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- February 2024
- 116 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- February 2024
- 114 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- May 2024
- 130 Pages
Global
From €2794EUR$3,160USD£2,412GBP
€3492EUR$3,950USD£3,015GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2466EUR$2,789USD£2,129GBP
- Report
- June 2025
- 250 Pages
Mexico
From €2466EUR$2,789USD£2,129GBP
- Report
- June 2025
- 250 Pages
Vietnam
From €2466EUR$2,789USD£2,129GBP
- Report
- June 2025
- 250 Pages
Brazil
From €2466EUR$2,789USD£2,129GBP
- Report
- June 2025
- 250 Pages
Japan
From €2466EUR$2,789USD£2,129GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more